Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nana Iriguchi"'
Autor:
Yuya Hirasawa, Yutaro Kubota, Emiko Mura, Risako Suzuki, Toshiaki Tsurui, Nana Iriguchi, Tomoyuki Ishiguro, Ryotaro Ohkuma, Masahiro Shimokawa, Hirotsugu Ariizumi, Atsushi Horiike, Satoshi Wada, Takeshi Yamashita, Tomotake Ariyoshi, Satoru Goto, Koji Otsuka, Masahiko Murakami, Yuji Kiuchi, Kiyoshi Yoshimura, Takuya Tsunoda
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionImmune checkpoint inhibitors (ICIs) have emerged as a promising treatment option for esophageal cancer (EC). Although ICIs enable long-term survival in some patients, the efficacy of ICIs varies widely among patients. Therefore, predictiv
Externí odkaz:
https://doaj.org/article/ec9c13c60c4d45eb834f44c57b5372fe
Autor:
Ryotaro Ohkuma, Sakiko Miura, Satoshi Muto, Yoshitaka Toyomasu, Yuki Fujimoto, Katsuaki Ieguchi, Nobuyuki Onishi, Takashi Shimizu, Makoto Watanabe, Daisuke Takayanagi, Tsubasa Goshima, Atsushi Horiike, Kazuyuki Hamada, Hirotsugu Ariizumi, Masahiro Shimokawa, Yuya Hirasawa, Tomoyuki Ishiguro, Risako Suzuki, Nana Iriguchi, Toshiaki Tsurui, Emiko Mura, Sachiko Takenoshita, Kazuki Numajiri, Naoyuki Okabe, Kiyoshi Yoshimura, Mayumi Tsuji, Yuji Kiuchi, Toshiki Yajima, Hideyuki Ishida, Hiroyuki Suzuki, Toshiko Yamochi, Shinichi Kobayashi, Takuya Tsunoda, Satoshi Wada
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionProgrammed cell death ligand 1 (PD-L1) expression in tumor tissues is measured as a predictor of the therapeutic efficacy of immune checkpoint inhibitors (ICIs) in many cancer types. PD-L1 expression is evaluated by immunohistochemical st
Externí odkaz:
https://doaj.org/article/ae7a3794a1b04272bd831501907f335c
Autor:
Risako Suzuki, Kazuyuki Hamada, Ryotaro Ohkuma, Mayumi Homma, Toshiaki Tsurui, Nana Iriguchi, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Yutaro Kubota, Atsushi Horiike, Kiyoshi Yoshimura, Satoshi Wada, Toshiko Yamochi, Takuya Tsunoda
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundCancer of unknown primary (CUP) is a malignant tumor without a known primary lesion with a frequency of 3−5%. It can be divided into favorable and unfavorable prognosis subsets. While recommended treatments are available for the former gr
Externí odkaz:
https://doaj.org/article/e2477a64a1da4c75b2af29bfc6cb2d4a
Autor:
Tomoyuki Ishiguro, Daisuke Takayanagi, Toshiaki Tsurui, Risako Suzuki, Nana Iriguchi, Yuya Hirasawa, Ryotaro Ohkuma, Hirotsugu Ariizumi, Yutaro Kubota, Kazuyuki Hamada, Atsushi Horiike, Satoshi Wada, Kiyoshi Yoshimura, Kazuyoshi Takeda, Takuya Tsunoda
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::620df439a8eee97e9741416a4403f6b6
https://doi.org/10.1136/jitc-2022-sitc2022.0046
https://doi.org/10.1136/jitc-2022-sitc2022.0046
Autor:
Ryotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, Tsubasa Goshima, Rie Onoue, Kazuyuki Hamada, Yutaro Kubota, Atsushi Horiike, Toshiaki Tsurui, Risako Suzuki, Nana Iriguchi, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Kiyoshi Yoshimura, Mayumi Tsuji, Yuji Kiuchi, Shinichi Kobayashi, Takuya Tsunoda, Satoshi Wada
Publikováno v:
Cancer Research. 82:6179-6179
Background: Immune checkpoint inhibitors (ICIs), like PD-1 and PD-L1 blockade therapies, are currently considered as one of the most significant breakthroughs in potent cancer immunotherapy. However, many patients are non-responders or develop resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d1017f86e5440f51fc3ccc478ec8d3b
https://doi.org/10.1158/1538-7445.am2022-6179
https://doi.org/10.1158/1538-7445.am2022-6179
Autor:
Seigo Nakamura, Takuya Tsunoda, Satoshi Matsukuma, Ryotaro Ohkuma, Kengo Takeuchi, Hirotsugu Ariizumi, Atsushi Horiike, Shunji Takahashi, Junji Tsurutani, Satoshi Wada, Nana Iriguchi, Yutaro Kubota, Kiyoshi Yoshimura, Shigetoshi Nishihara, Toshiko Yamochi, Reiko Yoshida, Tomoyuki Ishiguro, Ryosuke Hanaoka
Publikováno v:
Annals of Oncology. 32:S355
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::719afbc7845c7bed5c37d902d7b9e77a
https://doi.org/10.1016/j.annonc.2021.05.769
https://doi.org/10.1016/j.annonc.2021.05.769